Pat;
The fact that Thratec is losing money is an indication of what could be lack of good financial management. Unfortunately I am not qualified to bid an opinion.
What I do find encouraging (from a business point of view), is the fact that there is an sufficient demand for a 2nd generation product, that is allowing them to generate so much revenue.
This is not a 3rd gen. product, nor does it have the same saftey record, or the fda approval for a BTT let alone a DT!!!.....and they are still generating revenue.
Cheers
- Forums
- ASX - By Stock
- VCR
- fda there is no easy road
VCR
ventracor limited
fda there is no easy road, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)